Pre-order Enquiry
Request Free Sample
Global Personalized Cancer Medicine Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15133894 | Publishing Date : 28-Jan-2020 | No. of pages : 96
Detailed TOC of Global Personalized Cancer Medicine Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Personalized Cancer Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Personalized Cancer Vaccines
1.4.4 Other
1.5 Market by Application
1.5.1 Global Personalized Cancer Medicine Market Share by Application: 2020 VS 2026
1.5.2 Breast Cancer
1.5.3 Lung Cancer
1.5.4 Chronic Myeloid Leukaemia
1.5.5 Bowel Cancer
1.5.6 Other Cancer
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Personalized Cancer Medicine Market Perspective (2015-2026)
2.2 Personalized Cancer Medicine Growth Trends by Regions
2.2.1 Personalized Cancer Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Personalized Cancer Medicine Historic Market Share by Regions (2015-2020)
2.2.3 Personalized Cancer Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Personalized Cancer Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key Personalized Cancer Medicine Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Medicine Players by Market Size
3.1.1 Global Top Personalized Cancer Medicine Players by Revenue (2015-2020)
3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Personalized Cancer Medicine Market Concentration Ratio
3.2.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2019
3.3 Personalized Cancer Medicine Key Players Head office and Area Served
3.4 Key Players Personalized Cancer Medicine Product Solution and Service
3.5 Date of Enter into Personalized Cancer Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Personalized Cancer Medicine Historic Market Size by Type (2015-2020)
4.2 Global Personalized Cancer Medicine Forecasted Market Size by Type (2021-2026)
5 Personalized Cancer Medicine Breakdown Data by Application (2015-2026)
5.1 Global Personalized Cancer Medicine Market Size by Application (2015-2020)
5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Personalized Cancer Medicine Market Size (2015-2020)
6.2 Personalized Cancer Medicine Key Players in North America (2019-2020)
6.3 North America Personalized Cancer Medicine Market Size by Type (2015-2020)
6.4 North America Personalized Cancer Medicine Market Size by Application (2015-2020)
7 Europe
7.1 Europe Personalized Cancer Medicine Market Size (2015-2020)
7.2 Personalized Cancer Medicine Key Players in Europe (2019-2020)
7.3 Europe Personalized Cancer Medicine Market Size by Type (2015-2020)
7.4 Europe Personalized Cancer Medicine Market Size by Application (2015-2020)
8 China
8.1 China Personalized Cancer Medicine Market Size (2015-2020)
8.2 Personalized Cancer Medicine Key Players in China (2019-2020)
8.3 China Personalized Cancer Medicine Market Size by Type (2015-2020)
8.4 China Personalized Cancer Medicine Market Size by Application (2015-2020)
9 Japan
9.1 Japan Personalized Cancer Medicine Market Size (2015-2020)
9.2 Personalized Cancer Medicine Key Players in Japan (2019-2020)
9.3 Japan Personalized Cancer Medicine Market Size by Type (2015-2020)
9.4 Japan Personalized Cancer Medicine Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Personalized Cancer Medicine Market Size (2015-2020)
10.2 Personalized Cancer Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Personalized Cancer Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Personalized Cancer Medicine Market Size by Application (2015-2020)
11 India
11.1 India Personalized Cancer Medicine Market Size (2015-2020)
11.2 Personalized Cancer Medicine Key Players in India (2019-2020)
11.3 India Personalized Cancer Medicine Market Size by Type (2015-2020)
11.4 India Personalized Cancer Medicine Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Personalized Cancer Medicine Market Size (2015-2020)
12.2 Personalized Cancer Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Personalized Cancer Medicine Market Size by Type (2015-2020)
12.4 Central & South America Personalized Cancer Medicine Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Personalized Cancer Medicine Introduction
13.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview and Its Total Revenue
13.2.3 Merck Personalized Cancer Medicine Introduction
13.2.4 Merck Revenue in Personalized Cancer Medicine Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview and Its Total Revenue
13.3.3 Novartis Personalized Cancer Medicine Introduction
13.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview and Its Total Revenue
13.4.3 Amgen Personalized Cancer Medicine Introduction
13.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 Celgene
13.5.1 Celgene Company Details
13.5.2 Celgene Business Overview and Its Total Revenue
13.5.3 Celgene Personalized Cancer Medicine Introduction
13.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2015-2020)
13.5.5 Celgene Recent Development
13.6 Bayer
13.6.1 Bayer Company Details
13.6.2 Bayer Business Overview and Its Total Revenue
13.6.3 Bayer Personalized Cancer Medicine Introduction
13.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2015-2020)
13.6.5 Bayer Recent Development
13.7 Roche
13.7.1 Roche Company Details
13.7.2 Roche Business Overview and Its Total Revenue
13.7.3 Roche Personalized Cancer Medicine Introduction
13.7.4 Roche Revenue in Personalized Cancer Medicine Business (2015-2020)
13.7.5 Roche Recent Development
13.8 Astellas
13.8.1 Astellas Company Details
13.8.2 Astellas Business Overview and Its Total Revenue
13.8.3 Astellas Personalized Cancer Medicine Introduction
13.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2015-2020)
13.8.5 Astellas Recent Development
13.9 Astrazeneca
13.9.1 Astrazeneca Company Details
13.9.2 Astrazeneca Business Overview and Its Total Revenue
13.9.3 Astrazeneca Personalized Cancer Medicine Introduction
13.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2015-2020)
13.9.5 Astrazeneca Recent Development
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Details
13.10.2 Johnson & Johnson Business Overview and Its Total Revenue
13.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction
13.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2015-2020)
13.10.5 Johnson & Johnson Recent Development
13.11 Agilent
10.11.1 Agilent Company Details
10.11.2 Agilent Business Overview and Its Total Revenue
10.11.3 Agilent Personalized Cancer Medicine Introduction
10.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2015-2020)
10.11.5 Agilent Recent Development
13.12 Takeda
10.12.1 Takeda Company Details
10.12.2 Takeda Business Overview and Its Total Revenue
10.12.3 Takeda Personalized Cancer Medicine Introduction
10.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2015-2020)
10.12.5 Takeda Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Personalized Cancer Medicine Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Personalized Cancer Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Personalized Cancer Medicine Revenue
Table 3. Ranking of Global Top Personalized Cancer Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Personalized Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Personalized Cancer Vaccines
Table 7. Key Players of Other
Table 8. Global Personalized Cancer Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Personalized Cancer Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Personalized Cancer Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Personalized Cancer Medicine Market Share by Regions (2015-2020)
Table 12. Global Personalized Cancer Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Personalized Cancer Medicine Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Personalized Cancer Medicine Market Growth Strategy
Table 18. Main Points Interviewed from Key Personalized Cancer Medicine Players
Table 19. Global Personalized Cancer Medicine Revenue by Players (2015-2020) (Million US$)
Table 20. Global Personalized Cancer Medicine Market Share by Players (2015-2020)
Table 21. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Medicine as of 2019)
Table 22. Global Personalized Cancer Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Personalized Cancer Medicine Product Solution and Service
Table 25. Date of Enter into Personalized Cancer Medicine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 28. Global Personalized Cancer Medicine Market Size Share by Type (2015-2020)
Table 29. Global Personalized Cancer Medicine Revenue Market Share by Type (2021-2026)
Table 30. Global Personalized Cancer Medicine Market Size Share by Application (2015-2020)
Table 31. Global Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 32. Global Personalized Cancer Medicine Market Size Share by Application (2021-2026)
Table 33. North America Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 35. North America Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 36. North America Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 37. North America Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 38. North America Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 39. Europe Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 41. Europe Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 43. Europe Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 45. China Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 46. China Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 47. China Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 48. China Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 49. China Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 50. China Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 51. Japan Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 53. Japan Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 55. Japan Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 59. Southeast Asia Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 61. Southeast Asia Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 63. India Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 64. India Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 65. India Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 66. India Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 67. India Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 68. India Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 71. Central & South America Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 73. Central & South America Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Product
Table 78. Abbott Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 79. Abbott Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Product
Table 83. Merck Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 84. Merck Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. Amgen Company Details
Table 91. Amgen Business Overview
Table 92. Amgen Product
Table 93. Amgen Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 94. Amgen Recent Development
Table 95. Celgene Company Details
Table 96. Celgene Business Overview
Table 97. Celgene Product
Table 98. Celgene Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 99. Celgene Recent Development
Table 100. Bayer Company Details
Table 101. Bayer Business Overview
Table 102. Bayer Product
Table 103. Bayer Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 104. Bayer Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Product
Table 108. Roche Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 109. Roche Recent Development
Table 110. Astellas Business Overview
Table 111. Astellas Product
Table 112. Astellas Company Details
Table 113. Astellas Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 114. Astellas Recent Development
Table 115. Astrazeneca Company Details
Table 116. Astrazeneca Business Overview
Table 117. Astrazeneca Product
Table 118. Astrazeneca Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 119. Astrazeneca Recent Development
Table 120. Johnson & Johnson Company Details
Table 121. Johnson & Johnson Business Overview
Table 122. Johnson & Johnson Product
Table 123. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 124. Johnson & Johnson Recent Development
Table 125. Agilent Company Details
Table 126. Agilent Business Overview
Table 127. Agilent Product
Table 128. Agilent Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 129. Agilent Recent Development
Table 130. Takeda Company Details
Table 131. Takeda Business Overview
Table 132. Takeda Product
Table 133. Takeda Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 134. Takeda Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Cancer Medicine Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Personalized Cancer Vaccines Features
Figure 4. Other Features
Figure 5. Global Personalized Cancer Medicine Market Share by Application: 2020 VS 2026
Figure 6. Breast Cancer Case Studies
Figure 7. Lung Cancer Case Studies
Figure 8. Chronic Myeloid Leukaemia Case Studies
Figure 9. Bowel Cancer Case Studies
Figure 10. Other Cancer Case Studies
Figure 11. Personalized Cancer Medicine Report Years Considered
Figure 12. Global Personalized Cancer Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Personalized Cancer Medicine Market Share by Regions: 2020 VS 2026
Figure 14. Global Personalized Cancer Medicine Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Personalized Cancer Medicine Market Share by Players in 2019
Figure 17. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Medicine as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2019
Figure 19. North America Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 28. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Merck Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 32. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 34. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Celgene Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 36. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bayer Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 38. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 40. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Astellas Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 42. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Astrazeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 44. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 46. Agilent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Agilent Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 48. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Keyplayers in Global Personalized Cancer Medicine Market Size, Status and Forecast 2020-2026
AbbottMerck
Novartis
Amgen
Celgene
Bayer
Roche
Astellas
Astrazeneca
Johnson & Johnson
Agilent
Takeda
Request Sample
Request Discount
